Our mission
“Redefining Neuroprotection Through Multiple Mechanisms“
Enemsa Pharma develops next-generation therapies that restore proteostasis, enhance mitophagy, reduce oxidative stress and protect vulnerable neurons, as standalone treatments and in synergistic combination approaches for neurodegenerative diseases.
Latest news
Event
Enemsa Pharma is pleased to announce its participation in the BIO International Convention, taking place from June 22 to 25, 2026, in San Diego, USA. We look forward to meeting our partners and industry peers to explore new business collaboration opportunities.
See event
Enemsa Pharma is pleased to announce its participation in the BIO-Europe Conference, taking place from November 9 to 11, 2026 in Cologne, Germany. We look forward to meeting our partners and industry colleagues to discuss potential collaborations and new business opportunities.
See event 
Enemsa Pharma is pleased to announce its attendance at the 31st world congress on “Parkinson’s Disease and related disorders” to be held in Milano, Italy from November 11 to 14, 2026.
See event